Ocular Therapeutix: Q4 Earnings Snapshot

BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Monday reported a loss of $29.2 million in its fourth quarter.

The Bedford, Massachusetts-based company said it had a loss of 35 cents per share. Losses, adjusted for non-recurring costs, came to 28 cents per share.

The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 28 cents per share.

The biotechnology company posted revenue of $14.8 million in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $15.3 million.

For the year, the company reported a loss of $80.7 million, or $1.02 per share. Revenue was reported as $58.4 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL